Glass Health provides an AI platform that assists clinicians in generating differential diagnoses and drafting clinical plans based on patient summaries. By utilizing a large language model alongside evidence-based clinical guidelines, the platform enhances diagnostic accuracy and streamlines the development of treatment strategies.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BLIC+1Founders
Product
Problem
Clinicians often face challenges in efficiently generating comprehensive differential diagnoses and drafting clinical plans, especially when dealing with complex patient cases. The process can be time-consuming and may not always incorporate the latest evidence-based guidelines.
Solution
Glass Health offers an AI-powered clinical decision support (CDS) platform designed to assist clinicians in developing differential diagnoses and drafting assessment and plans. The platform analyzes patient summaries and suggests potential diagnoses, leveraging a large language model combined with evidence-based, peer-reviewed clinical guidelines maintained by a physician team. Glass Health aims to enhance diagnostic accuracy and streamline the development of treatment strategies by generating initial drafts of clinical plans for clinicians to review and refine. The platform's features are not designed for processing medical images or signals from in vitro diagnostic devices.
Target Audience
The primary users are clinicians seeking to improve their clinical decision-making process, enhance diagnostic accuracy, and streamline the creation of treatment plans.
Features
- AI-driven analysis of patient summaries to suggest potential diagnoses.
- Generation of draft clinical plans based on evidence-based guidelines.
- Integration of a large language model with peer-reviewed clinical content.
- Support for drafting differential diagnoses, assessments & plans, and answers to clinical reference questions.